SciELO - Scientific Electronic Library Online

vol.44 issue6Molecular characterization of clinical multiresistant isolates of Acinetobacter sp. from hospitals in Porto Alegre, State of Rio Grande do Sul, BrazilValidation of a case definition for leptospirosis diagnosis in patients with acute severe febrile disease admitted in reference hospitals at the State of Pernambuco, Brazil author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand



Related links


Revista da Sociedade Brasileira de Medicina Tropical

Print version ISSN 0037-8682

Rev. Soc. Bras. Med. Trop. vol.44 no.6 Uberaba Nov./Dec. 2011 



Reduction of catheter-associated bloodstream infections through procedures in newborn babies admitted in a university hospital intensive care unit in Brazil


Redução de infecções de corrente sanguínea associadas ao cateter, após procedimentos em neonatos admitidos em uma unidade de teapia intensiva de um hospital universitário no Brasil



Daiane Silva ResendeI; Jacqueline Moreira do ÓI; Denise von Dolinger de BritoI; Vânia Olivetti Steffen AbdallahII; Paulo Pinto Gontijo FilhoI

ILaboratório de Microbiologia, Instituto de Ciências Biomédicas, Universidade Federal de Uberlândia, Uberlândia, MG
IIDepartamento de Neonatologia, Faculdade de Medicina, Uberlândia, MG

Address to




INTRODUCTION: Catheter-associated bloodstream infection (CA-BSI) is the most common nosocomial infection in neonatal intensive care units. There is evidence that care bundles to reduce CA-BSI are effective in the adult literature. The aim of this study was to reduce CA-BSI in a Brazilian neonatal intensive care unit by means of a care bundle including few strategies or procedures of prevention and control of these infections.
METHODS: An intervention designed to reduce CA-BSI with five evidence-based procedures was conducted.
RESULTS: A total of sixty-seven (26.7%) CA-BSIs were observed. There were 46 (32%) episodes of culture-proven sepsis in group preintervention (24.1 per 1,000 catheter days [CVC days]). Neonates in the group after implementation of the intervention had 21 (19.6%) episodes of CA-BSI (14.9 per 1,000 CVC days). The incidence of CA-BSI decreased significantly after the intervention from the group preintervention and postintervention (32% to 19.6%, 24.1 per 1,000 CVC days to 14.9 per 1,000 CVC days, p=0.04). In the multiple logistic regression analysis, the use of more than 3 antibiotics and length of stay >8 days were independent risk factors for BSI.
CONCLUSIONS: A stepwise introduction of evidence-based intervention and intensive and continuous education of all healthcare workers are effective in reducing CA-BSI.

Keywords: Neonates. Bloodstream infection. Reduction. Central venous catheter.


INTRODUÇÃO: As infecções de corrente sanguínea associadas ao cateter (ICS-AC) são as infecções hospitalares mais frequentes em unidades de terapia intensiva neonatais. O objetivo do nosso estudo foi reduzir as ICS-AC através de um pacote de medidas de cuidados incluindo algumas estratégias de controle e prevenção destas infecções.
MÉTODOS: Foi realizada uma intervenção desenhada para reduzir as infecções de corrente sanguínea associadas ao cateter com cinco procedimentos de base.
RESULTADOS: Um total de 67 (26,7%) ICS-AC foi observado. Houve 46 (32%) episódios de sepse com critério microbiológico (24,1 por 1.000 catater dias(CVC-dias). Os neonatos do grupo, após a implementação da intervenção, tiveram 21 (19,6%) episódios de ICS-AC (14,9 por 1.000 CVC-dias). A incidência de ICS-AC reduziu significantemente entre os grupos pré-intervenção e pós-intervenção após a implementação das medidas (32% para 19.6%, 24.1 por 1.000 CVC-dias para 14.9 por 1.000 CVC-dias, p=0.04). Na análise de regressão logística múltipla, o uso de > três antibióticos e tempo de hospitalização > 8 dias foram fatores de risco independentes para ICS.
CONCLUSÕES: A introdução de uma intervenção baseada em evidências e a educação intensiva e continuada de todos os profissionais de saúde são efetivas para a redução de ICS-AC.

Palavras-chaves: Neonatos. Infecção de corrente sanguínea. Redução. Cateter venoso central.




Hospital-acquired infection is a significant cause of morbidity and mortality in neonatal intensive care units (NICUs)1 and leads to an increase in the length of stay and hospital costs2. Bloodstream infections (BSIs) are the most common healthcare-associated infection in neonates3-4. Very limited information is available from developing countries on infection rates per hospital-days or device-days including Brazilian units5. Incidence density rates per healthcare-associated infection in few studies6-7 were higher than those observed in most studies in the United States or Europe8.

Risk factors associated to BSI include prematurity, low birth weight, poor skin integrity, low gestational age, use of parenteral nutrition (PN), central venous catheter (CVC), prolonged duration of NICU stay, and exposure to broad-spectrum antibiotics3,8.

To reduce these infections, guidelines and, recently, bundles of practices have been shown effective in preventing a large proportion of catheter-associated BSI (CA-BSI)2,9-10. These bundles include ongoing surveillance, healthcare workers' education, a trained team of caregivers for catheter insertion and care, and strategies designed to prevent intraluminally and extraluminally acquired BSIs11-12.

The aim of this study was to reduce CA-BSIs in a Brazilian NICU by means of a bundle, including few evidence-based strategies or procedures recommended by the Centers for Disease Control and Prevention (CDC) to reduce risks of CA-BSIs.



Design of the study

The study was conducted in the NICU of the University Hospital of Uberlândia. All neonates admitted between August 2008 and September 2009 who required at least one CVC were included in this trial. An epidemiological surveillance for evaluation of nosocomial infection occurrence in the NICU was performed by a team trained by a physician according to the National Healthcare Safety Network, with daily visits to the unit to search BSI and possible risk factors and to the hospital laboratory to recover positive cultures isolated from infections in neonates hospitalized in the period of the trial. Patients were followed from their entry into the study to their discharge or death. An intervention to reduce BSI was followed up from April 2009 to May 2009. Standard definitions for healthcare-associated infections were used13. The ethical approval was obtained from the ethics committee of the Federal University of Uberlândia according to the Health Ministry demands.


Before implementing any of the components of the study intervention, one physician was designated as the leader. This leader was supposed to train the colleagues about intervention measures. Literature was assessed for methodological quality and applicability and based primarily on categories IA and IB, and guidelines were drafted for CVC insertion and maintenance.

The intervention focused on group sessions and feedback on pathogenesis and data of CA-BSI per 1,000 CVC days in the unit before intervention. Emphasis was placed in five evidence-based procedures (bundle) recommended by the CDC and identified as having the greatest effect on the rate of CA-BSI and the lowest barriers to implementation9,14. The recommended procedures are hand hygiene, using full-barrier precautions during the insertion of CVCs, cleaning the skin with chlorhexidine 0.2%, avoiding the femoral site if possible, and removing unnecessary catheters besides better knowledge about prevention of CA-BSI in neonates. At the first meeting, the pathogenesis and rates of BSI in the unit before intervention (August 2008 to March 2008) were discussed. In the second meeting, the procedures to prevent BSI were addressed. Emphasis was placed on identifying solutions to overcome difficulties to comply with the bundle. Otherwise, visual displays with A3-size color posters that emphasized care with CVC were distributed at strategic points of the unit.


Epidemiological surveillance was also performed in the post-intervention period (June 2009 to September 2009). Rates of BSI on this period were calculated per 1,000 CVC days and then presented to healthcare workers as a feedback on the epidemiological indicators of CA-BSI in the unit. Differences in proportions of BSI between the two periods were compared by conducting a statistical analysis.

Microbiological techniques

Hemocultures: blood cultures were collected based on clinical criteria, including apnea, bradycardia, temperature instability, feed intolerance, increased oxygen requirement, fever, and lethargy. To avoid contamination of blood cultures, a specialized nurse drew blood after meticulous skin cleaning. Blood was processed using the BACTEC 9240 (Becton Dickinson Diagnostic Instrument Systems, Sparks, MD, USA) method. Positive cultures were further subcultured in blood agar plates.

Microorganism identification

The identification of samples was performed through traditional phenotype tests15.

Statistical analysis

Two periods were compared to evaluate the impact of the intervention: the period before the start of intervention (Group 1) and the period after initiation of the intervention (Group 2). Categorical variables were compared using the Chi-square test or the Mann-Whitney U test when appropriate. Univariate analysis of risk factors for BSI was performed by applying the Chi-square test. Statistical significance level was set at p<0.05. The variables with p<0.05 in the univariate analyses were included in the multivariate logistic regression model to identify independent risk factors for BSI. Software BioStat version 5.0 (Brazil) was used for multiple logistic regression, and GraphPad Prism (Version 5.0, San Diego, USA) was used for other analyses.



A total of 251 neonates submitted to CVC use were included in this study. One hundred forty-four neonates were admitted before the intervention (Group 1), and 107 neonates were admitted after the implementation of the five evidence-based procedures (bundle) in the NICU (Group 2). No significant differences were observed between the patients' characteristics in both groups (Table 1).



A total of sixty-seven (26.7%) CA-BSIs were observed in the unit. Microbiological criteria were possible for most (91.7%) clinical sepsis. There were 46 (32%) episodes of culture-proven sepsis in Group 1. The most common organisms were coagulase negative Staphylococcus (CNS) (50%), mainly Staphylococcus epidermidis (46.2%), followed by Staphylococcus aureus (15.4%), Gram-negative bacilli (15.3%), Candida spp. (7.8%), and Enterococcus faecalis (5.8%). The incidence densities of CA-BSI on the preintervention period were 24.1 per 1,000 CVC days and 21.9 per 1,000 patients days, and the median of central line days was 13.2 (Table 2). Group 2 neonates had 21 (19.6%) episodes of BSI, seven due to CNS (35%), mainly S. epidermidis (30%); eight were attributable to S. aureus (40%), and three were due to Gram-negative bacilli (15%). The incidence densities of CA-BSI were 14.9 per 1,000 CVC days and 12.5 per 1,000 patient days, with a median of central line days of 13.2 (Table 1).



Figure 1 shows that incidence of BSI decreased significantly after the intervention measures from Group 1 to Group 2, 32% to 19.6% (p=0.04). The incidence rate of CA-BSI per 1,000 CVC days also decreased significantly between the groups from 24.1 per 1,000 CVC days to 14.9 per 1,000 CVC days, and that of CA-BSI per 1,000 neonate days decreased from 21.9 per 1,000 neonate days to 12.5 per 1,000 neonate days; however, the average central line length was the same (13.2) in both groups (Table 1).



Overall, the use of PN (p=0.04) and mechanical ventilation (p=0.02), exposure to >3 antibiotics (p<0.001), and length of stay >8 days (p<0.001) were risk factors for BSI as determined by univariate analysis. The use of more than 3 antibiotics (OR=5.25, p<0.001, 95% CI=2.68-1,030) and length of stay >8 days (OR=2.57, p=0.01, 95% CI=1.18-5.61) were found to be independent risk factors for BSI by the multiple logistic regression analysis.

Analyses were repeated for a subgroup of low-birth-weight infants (<1,500g). A total of 113 low-birth-weight infants were included, 67 in Group 1 and 46 in Group 2. There were 25 episodes of culture-proven sepsis in Group 1 and 7 episodes in Group 2. The rate of BSI decreased significantly from Group 1 to Group 2 (37.3% to 15.2%, respectively, p<0.01). Central line use was similar in both groups. The incidence density rate of CA-BSI per 1,000 CVC days decreased between groups (26.2 per 1,000 CVC days to 10.2 per 1,000 CVC days), and CA-BSI per 1,000 neonate days decreased from 23.6 per 1,000 neonate days to 9.3 per 1,000 neonate days (Table 2).



In this report, we affirm the effectiveness of evidence-based prevention bundles in reducing the rate of CA-BSI in our NICU patients. To our knowledge, this is the first study to evaluate the impact of an intervention aimed to decrease CA-BSI among neonates in a Brazilian NICU.

Neonatal BSI is a commonly encountered hospital infection among neonates, mainly premature infants, particularly those who require a CVC1. Unfortunately, the use of these devices is associated with a considerable risk of infection16. Of note in both adult and neonatal ICUs, in developing countries, such as Brazil, device-associated infection rates are reported to be several-fold higher than those detected by The National Nosocomial Infection Surveillance in the United States, 16.1 for five developing countries against 6.6 for the US17. For example, CA-BSIs per 1,000 CVC days occur at rates of 3.1-6.4 in NICUS according to The National Healthcare Safety Network and 22.7 in seven units located in the Brazilian cities3. Our preintervention rate of CA-BSI was similar (24.1) and much higher than those from developed countries17.

CA-BSIs are largely preventable, and many studies have been published documenting the effectiveness of interventions; reports of several studies have revealed a reduction in CA-BSI rates. Most available data from these interventions are related to adult units14,18 and some in pediatrics units10,19. In settings with limited resources, in infants, few data have been published2,20.

In our NICU, we used simple and inexpensive intervention to increase compliance with evidence-based infection control practices and decrease CA-BSI rates. After implementation of the bundle, CA-BSI rate, CA-BSI per 1,000 CVC days, and CA-BSI per 1,000 neonate days had decreased from 32% to 19.6%, 24.1 to 14.9, and 21.9 to 12.5, respectively. The rate of BSI also decreased significantly from Group 1 to Group 2. In low-birth-weight neonates, the rates decreased from 37.3% and 15.2%. We observed a reduction of CA-BSI per 1,000 CVC days and CA-BSI per 1,000 neonate days, observed in association with the new practices, from 26.2 to 10.2 and 23.6 to 9.3, respectively. We have shown that specific education and recommended procedures of CVC insertion and care and feedback to healthcare workers (HCWs) can result in significant reduction on rates of CA-BSI. The overall compliance to the catheter care policy improved significantly in the post-intervention period. Leadership came from within the NICU, which, we think, increased our ability to achieve cooperation from the healthcare workers and to create a change in culture regarding CA-BSI prevention and might explain the success of our intervention.

Coagulase-negative Staphylococcus is the most common cause of late-onset BSI in our NICU, accounting for 45.8%, similar to the observations in developed countries, where CNS is the most important microorganism causing CA-BSI8,12. Other studies have shown previously that CNSes were the most frequent agents of BSI as in our NICU7. In contrast, Gram-negative bacilli, mainly Klebsiella spp., Escherichia coli, and Enterobacter spp., were most frequent in developing countries5-6.

In this report, the multivariate analysis identified just two independent risk factors for BSI: exposure to >3 antibiotics and length of stay >8 days. Risk factors found in previous studies include these, as well as parenteral nutrition and very low birth weight in infants21. Parenteral nutrition and mechanic ventilation may be stronger predictors of BSI than CVC use only22 but were not used in a minority of our infants (24.3) and was significant only in the univariate analysis.

There are some limitations in our study. First, we did not collect data of factors that could influence CA-BSI rates such as the line type that was placed and the healthcare worker who placed the line or its duration of use. We are not aware of any market changes, and the procedures have been shown not to change substantially over time; it is likely that the groups remained similar. The postintervention period was only four months, so it was unlikely that there were significant changes.

Second, we did not collect data on preintervention process to measure compliance, and this lack of data decreased our ability to measure the full impact of the bundles, although it is unlikely that the precollaborative performances were markedly different from those in the initial months of the project.

In conclusion, education can significantly improve infection control practices. We implement a simple intervention to reduce these infections in a university NICU. Coinciding with the intervention, the median rate decreased from 24.1 to 14.9 per 1,000 CVC days. We think that it is feasible to sustain this intervention over a long term. The challenge is to continue this reduction, considering the rate of CA-BSI in a university hospital, with more pronounced mobility of students, chiefs, and professionals in the unit.



The authors declare that there is no conflict of interest.



1. Posfay-Barbe KM, Zerr DM, Pittet D. Infection control in paediatrics. Lancet Infect Dis 2008; 1:19-31.         [ Links ]

2. Aly H, Herson V, Duncan A, Herr J, Bender J, Patel k, et al. Is bloodstream infection preventable among premature infants? A tale of two cities. Pediatrics 2005; 115:1513-1518.         [ Links ]

3. Pessoa-Silva C, Richtmann R, Calil R, Santos R, Costa M, Frota A, et al. Healthcare-associated infections among neonates in Brazil. Infect Control Hosp Epidemiol 2004; 25:772-777.         [ Links ]

4. Orsi GB, d'Ettorre G, Panero A, Chiarini F, Vullo V, Venditti M. Hospital-acquired infection surveillance in a neonatal intensive care unit. Am J Infect Control 2009; 37:201-203.         [ Links ]

5. Zaidi AK, Huskins WC, Thaver D, Bhutta ZA, Abbas Z, Goldmann DA. Hospital-acquired neonatal infections in developing countries. Lancet 2005; 365:1175-1188.         [ Links ]

6. Couto RC, Carvalho EA, Pedrosa TM, Pedroso ER, Neto MC, Biscione FM. A 10-year prospective surveillance of nosocomial infections in neonatal intensive care units. Am J Infect Control 2007; 35:183-189.         [ Links ]

7. Brito D, Almeida ES, Oliveira E, Arantes A, Abdallah VOS, Gontijo-Filho PP, et al. Effect of neonatal intensive care unit environment on the incidence of hospital-acquired infection in neonates. J Hosp Infect 2007; 65:314-318.         [ Links ]

8. Sohn A, Garrett D, Sinkowitz-Cochran R, Grohskopf L, Levine G, Stover B, et al. Pediatric Prevention Network Prevalence of nosocomial infections in neonatal intensive care unit patients: Results from the first national point-prevalence survey. J Pediatr 2001; 139:821-827.         [ Links ]

9. O'Grady N, Alexander M, Dellinger E, Gerberding J, Heard S, Maki D, et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. Pediatrics 2002; 51:1-29.         [ Links ]

10. Jeffries H, Mason W, Brewer M, Oakes K, Muñoz E, Gornick W, et al. Prevention of central venous catheter-associated bloodstream infections in pediatric intensive care units: a performance improvement collaborative. Infect Control Hosp Epidemiol 2009; 30:645-651.         [ Links ]

11. Borghesi A, Stronati M. Strategies for the prevention of hospital-acquired infections in the neonatal intensive care unit. J Hosp Infect 2008; 68:293-300.         [ Links ]

12. Garland JS, Uhing MR. Strategies to prevent bacterial and fungal infection in the neonatal intensive care unit. Clin Perinatol 2009; 36:1-13.         [ Links ]

13. The National Healthcare Safety Network (NHSN). Manual Patient Safety Component Protocol. Atlanta, GA, USA: Division of Healthcare Quality Promotion. National Center for Infectious Diseases; 2008.         [ Links ]

14. Pronovost P, Needham D, Berenholtz S, Sinopoli D, Chu H, Cosgrove S, et al. An Intervention to Decrease Catheter-Related Bloodstream Infections in the ICU. N Engl J Med 2006; 355:2725-2732.         [ Links ]

15. Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Winn WCJ. Color Atlas and Textbook of Diagnostic Microbiology. 5th ed. Rio de Janeiro: DC-MEDSI; 2001.         [ Links ]

16. Safdar N, Maki DG. Risk of catheter-related bloodstream infection with peripherally inserted central venous catheters used in hospitalized patients. Chest 2005; 128:489-495.         [ Links ]

17. Pittet D, Allegranzi B, Storr S, Bagheri S, Dziekan G, Leotsakos A, et al. Infection control as a major World Health Organization priority for developing countries. J Hosp Infect 2008; 68:285-292.         [ Links ]

18. Lobo R, Levin A, Gomes L, Cursino R, Park M, Figueiredo V, et al. Impact of an educational program and policy changes on decreasing catheter-associated bloodstream infections in a medical intensive care unit in Brazil. Am J Infect Control 2005; 33:83-87.         [ Links ]

19. Costello JM, Morrow DF, Graham DA, Potter-Bynoe G, Sandora TJ, Laussen PC. Systematic intervention to reduce central line-associated bloodstream infection rates in a pediatric cardiac intensive care unit. Pediatrics 2008; 121:915-923.         [ Links ]

20. Curry S, Honeycutt M, Goins G, Gilliam C. Catheter-Associated Bloodstream Infections in the NICU: Getting to Zero. Neonatal Netw 2009; 28:151-155.         [ Links ]

21. Perlman SE, Saiman L, Larson EL. Risk factors for late-onset health care-associated bloodstream infections in patients in neonatal intensive care units. Am J Infect Control 2007; 35:177-182 .         [ Links ]

22. Holmes A, Doré C J, Saraswatula A, Bamford K B, Richards M S, Coello R, et al. Risk factors and recommendations for rate stratification for surveillance of neonatal healthcare-associated bloodstream infection. J Hosp Infect 2008; 68:66-72.         [ Links ]



Address to:
MSc. Daiane Silva Resende
Laboratório de Microbiologia/ICBIM/UFU
Av. Pará 1720
Campus Umuarama, 38400-902 Uberlândia, MG, Brasil
Phone: 55 34 9204-5388

Received in 03/05/2011
Accepted in 29/07/2011

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License